What is CA Atra 10

CA Atra 10 is a prescription medication for Acute Promyelocytic Leukemia in adults and off-label in children. Its primary ingredient is Tretinoin (10 mg), a retinoic acid derivative and differentiation agent. Jenome Biophar Pvt Ltd manufactures CA Atra 10.

This oral Tretinoin therapy promotes cancer cell differentiation into normal mature cells. The medication targets promyelocytic leukemia cells and induces their maturation process. CA Atra 10 represents a breakthrough in leukemia treatment through a differentiation therapy approach.

Common CA Atra side effects include headache, fever, skin dryness, bone pain, and retinoic acid syndrome. Most side effects are manageable with proper medical supervision and supportive care. Serious side effects, including breathing difficulties or allergic reactions, require immediate medical attention.

Store CA Atra 10 mg in a cool, dry place away from direct sunlight and moisture. Keep capsules in their original packaging until use to protect from light exposure. Do not store in bathroom areas or places with high humidity levels.

Safety precautions include regular monitoring for retinoic acid syndrome during the initial treatment weeks. Patients should avoid vitamin A supplements and inform doctors about their pregnancy plans. Sun exposure should be minimized due to increased photosensitivity reactions.

What are the benefits of CA Atra 10

CA Atra 10 works by binding to retinoic acid receptors specifically in promyelocytic leukemia cells. This binding triggers cellular differentiation pathways that transform immature cancer cells into mature cells. The medication effectively induces remission in Acute Promyelocytic Leukemia patients through this unique mechanism.

Tretinoin promotes normal cell development by activating genes responsible for cellular maturation processes. This differentiation approach preserves healthy blood cells while targeting only abnormal promyelocytes. The treatment provides high remission rates with fewer traditional chemotherapy-related complications.

Patients experience a better quality of life during treatment with manageable side effect profiles. Treatment success can be monitored through regular blood tests and bone marrow evaluations.

It is crucial to note that CA Atra capsules require careful monitoring for complications from retinoic acid syndrome.

How to take CA Atra 10

CA Atra 10 mg is a prescription medication that should be taken per your doctor's instructions. Here are the general guidelines:

• Take CA Atra 10 twice daily with meals to improve absorption and reduce stomach irritation. Swallow capsules whole with water without opening, crushing, or chewing them.
• Take it with meals at evenly spaced intervals throughout the day for consistent blood levels.
• Do not exceed the prescribed dosage or modify the timing without an oncologist’s consultation.

Strengths and substitutes

The strengths and substitutes available at Cheap Medicine Shop are:

View all substitutes

What are the side effects of CA Atra 10

CA Atra 10 mg is generally effective for leukemia treatment but requires careful monitoring. However, it may cause side effects, including:

• Headache
• Fever
• Skin dryness and peeling
• Bone and joint pain
• Nausea and loss of appetite

These adverse effects typically can be managed with supportive care and medical supervision throughout treatment.

Safety Advice

Liver disease

Patients with liver impairment should use CA Atra 10 with caution and regular monitoring. Reduced liver function can affect Tretinoin metabolism and may increase toxicity risks. Regular liver function tests are vital during treatment to detect potential hepatotoxicity. Dose modifications may be necessary based on individual liver function assessment results.

Kidney impairment

Individuals with kidney disease can generally use CA Atra 10 without significant dose adjustments. However, careful monitoring is recommended to assess overall treatment tolerance and response. Patients with severe kidney problems should receive specialized medical supervision during therapy. Healthcare providers should monitor kidney function periodically throughout the duration of treatment.

Pregnant and breastfeeding women

CA Atra 10 causes severe birth defects and must never be used during pregnancy. Women of childbearing potential must use effective contraception during treatment and for one month afterward. Pregnancy testing is required before starting treatment and during therapy. Breastfeeding should be discontinued as Tretinoin may pass into breast milk.

Avoid

Vitamin A supplements should be avoided entirely during CA Atra 10 treatment to prevent toxicity. Tetracycline antibiotics can increase intracranial pressure when combined with Tretinoin and should be avoided. Minimize sun exposure and use sunscreen as medication increases photosensitivity significantly. Avoid alcohol consumption as it may worsen liver function during treatment.